Skip to main content

Colon Adenoma

0
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Verily Life Sciences
1 program
Computer-Assisted DetectionN/A1 trial
Active Trials
NCT05275556Completed1,410Est. Oct 2022
Lumendi
LumendiCT - Westport
1 program
Double Balloon Endoluminal PlatformN/A1 trial
Active Trials
NCT03551379Completed15Est. Sep 2018
Olympus
OlympusPA - Center Valley
1 program
NBI FunctionN/A1 trial
Active Trials
NCT02009774Completed380Est. May 2015
Evergreen Therapeutics
Evergreen TherapeuticsChina - Hong Kong
1 program
Water exchange aloneN/A1 trial
Active Trials
NCT06173258Completed560Est. Jan 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Evergreen TherapeuticsWater exchange alone
Verily Life SciencesComputer-Assisted Detection
LumendiDouble Balloon Endoluminal Platform
OlympusNBI Function

Clinical Trials (4)

Total enrollment: 2,365 patients across 4 trials

NCT06173258Evergreen TherapeuticsWater exchange alone

Water Exchange Colonoscopy With Artificial Intelligence-assisted Detection

Start: Dec 2023Est. completion: Jan 2025560 patients
N/ACompleted
NCT05275556Verily Life SciencesComputer-Assisted Detection

Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)

Start: Mar 2022Est. completion: Oct 20221,410 patients
N/ACompleted
NCT03551379LumendiDouble Balloon Endoluminal Platform

A Double Balloon Endoscopic Platform for ESD

Start: Sep 2017Est. completion: Sep 201815 patients
N/ACompleted
NCT02009774OlympusNBI Function

Accuracy of the Optical Diagnosis of Small Colonic Polyps Using the Nice Classification

Start: Jan 2014Est. completion: May 2015380 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.